Discovery Partnerships 2014

In recent years we have seen a slow but steady paradigm shift in how pharmaceutical companies approach early drug discovery. The role of discovery partnerships in a high-failure-rate industry such as bio/pharma is thus pivotal for enhancing innovation while de-risking in the pre-clinical stages. Collaborative capabilities, when well developed, implemented and adopted combined with a realistic assessment of resources will define the value for science, infrastructure and business development in your company.

Our 5th annual Discovery Partnerships forum is an exclusive meeting point for interviewing potential partners, for informing yourself regarding the latest trends and for better understanding what type of partnership you should be investing in!

Join the only European non-clinical Discovery Partnerships forum and benefit from:

- The participation of high-level experts from
pharma, CROs, biotech and academia sharing from the long-year experience
- An interactive program which values networking and enables all participants to actively discuss their “burning” issues
- More than 10 case-studies analysing and arguing best practice methods for initiating & managing innovation-driven alliances

Featured Speakers :
Peter Simpson
Director, Discovery Sciences
AstraZeneca plc
Katja Rosenkranz
Senior Projektmanager
Ascenion GmbH
Frank Grams
VP Head R&D Alliance Management & Contracting
Sanofi
and many more..